Search research articles
Contact Us
Filters
Showing results (11-20 of 202) with videos related to
Page
of 21
Sort By:
Virology
|
February 20, 1995
Analysis of the role of the amino-terminal peptide of vaccinia virus structural protein precursors during proteolytic processing
P Lee, D E Hruby
Pharmaceutical Research
|
April 1, 1987
Use of vaccinia virus to express biopharmaceutical products
D E Hruby, G Thomas
The Journal of Biological Chemistry
|
October 15, 1990
Identification of the ATP-binding domain of vaccinia virus thymidine kinase
M E Black, D E Hruby
Biochimica Et Biophysica Acta
|
June 11, 1993
Further characterization of an adenosine-containing modification of vaccinia virus proteins
S J Child, D E Hruby
Journal of Virological Methods
|
July 6, 2004
Conditional expression of vaccinia virus genes in mammalian cell lines expressing the tetracycline repressor
Marika Hedengren-Olcott, Dennis E Hruby
The Journal of General Virology
|
June 1, 1994
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope
M P Ravanello, D E Hruby
Journal of Virology
|
August 1, 1977
Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translation
D E Hruby, W K Roberts
Virology Journal
|
July 13, 2007
Vaccinia virus A12L protein and its AG/A proteolysis play an important role in viral morphogenic transition
Su Jung Yang, Dennis E Hruby
Archives of Virology
|
January 1, 1987
Association of non-viral proteins with recombinant vaccinia virus virions
C A Franke, D E Hruby
Journal of Virology
|
May 30, 1998
Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment
D W Grosenbach, D E Hruby
Page
of 21
Search research articles
Search
Showing results (11-20 of 202) with videos related to
Sort By:
Page
of 21
Virology
|
February 20, 1995
Analysis of the role of the amino-terminal peptide of vaccinia virus structural protein precursors during proteolytic processing
P Lee, D E Hruby
Pharmaceutical Research
|
April 1, 1987
Use of vaccinia virus to express biopharmaceutical products
D E Hruby, G Thomas
The Journal of Biological Chemistry
|
October 15, 1990
Identification of the ATP-binding domain of vaccinia virus thymidine kinase
M E Black, D E Hruby
Biochimica Et Biophysica Acta
|
June 11, 1993
Further characterization of an adenosine-containing modification of vaccinia virus proteins
S J Child, D E Hruby
Journal of Virological Methods
|
July 6, 2004
Conditional expression of vaccinia virus genes in mammalian cell lines expressing the tetracycline repressor
Marika Hedengren-Olcott, Dennis E Hruby
The Journal of General Virology
|
June 1, 1994
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope
M P Ravanello, D E Hruby
Journal of Virology
|
August 1, 1977
Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translation
D E Hruby, W K Roberts
Virology Journal
|
July 13, 2007
Vaccinia virus A12L protein and its AG/A proteolysis play an important role in viral morphogenic transition
Su Jung Yang, Dennis E Hruby
Archives of Virology
|
January 1, 1987
Association of non-viral proteins with recombinant vaccinia virus virions
C A Franke, D E Hruby
Journal of Virology
|
May 30, 1998
Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment
D W Grosenbach, D E Hruby
Page
of 21